Evidence map›Paper›PMID 26410208›Full record

ArticleRestorative neurology and neuroscience2015

Involvement of the GABAergic system in the neuroprotective and sedative effects of acacetin 7-O-glucoside in rodents.

Javier Gálvez, Rosa Estrada-Reyes, Gloria Benítez-King, Gabriela Araujo, Sandra Orozco, Rodrigo Fernández-Mas, Salvador Almazán, Eduardo Calixto

Open access · hybridAbstract read
In one paragraph

Article in Restorative neurology and neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. An aqueous extract ofHeliyon · 2022
    Article
  3. Review
  4. The GenusFrontiers in pharmacology · 2022
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Javier GálvezDepartment of Neurobiology, National Institute of Psichiatry, D.F., México.
Rosa Estrada-ReyesLaboratory of Phytopharmacology, National Institute of Psichiatry, D.F., México.
Gloria Benítez-KingLaboratory of Neuropharmacology, National Institute of Psichiatry, D.F., México.
Gabriela AraujoLaboratory of Phytopharmacology, National Institute of Psichiatry, D.F., México.
Sandra OrozcoUnit of Medical Research in Neurologic Deseases (UIMEN), Hospital de Especialidades, Medical National Center Century XXI, Mexican Institute of Social Security, Av. Cuauhtémoc #330, Col. Doctores, Del. Cuauhtémoc, México, D.F., México.
Rodrigo Fernández-MasLaboratory of Neurophysiology of Control and Regulation, National Institute of Psichiatry, D.F., México.
Salvador AlmazánDepartament of Bioelectronics, National Institute of Psichiatry, D.F., México.
Eduardo CalixtoDepartment of Neurobiology, National Institute of Psichiatry, D.F., México.
BioElectronics (United States) · USMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCharacterization of sedative, possible anticonvulsant, and protective effects of Acacetin-7-O-glucoside (7-ACAG).

methods7-ACAG was separated and its purity was analyzed. Its sedative and anti-seizure effects (1, 10, 20, and 40 mg/kg) were evaluated in male mice. Synaptic responses were acquired from area CA1 of hippocampal slices obtained from male Wistar rats. Rats were subjected to stereotaxic surgeries to allow Electroencephalographic (EEG) recordings. Functional recovery was evaluated by measuring the time rats spent in completing the motor task. Then the rats were subjected to right hemiplegia and administered 7-ACAG (40 mg/kg) 1 h or 24 h after surgery. Brains of each group of rats were prepared for histological analysis.

resultsEffective sedative doses of 7-ACAG comprised those between 20 and 40 mg/kg. Latency and duration of the epileptiform crisis were delayed by this flavonoid. 7-ACAG decreased the synaptic response in vitro, similar to Gamma-aminobutyric acid (GABA) effects. The flavonoid facilitated functional recovery. This data was associated with preserved cytoarchitecture in brain cortex and hippocampus.

conclusions7-ACAG possesses anticonvulsive and sedative effects. Results suggest that GABAergic activity and neuroprotection are involved in the mechanism of action of 7-ACAG and support this compound's being a potential drug for treatment of anxiety or post-operative conditions caused by neurosurgeries.

Indexed as

AnimalsAnticonvulsantsCA1 Region, HippocampalCerebral CortexDisease Models, AnimalDose-Response Relationship, DrugDrug Evaluation, PreclinicalFlavonoidsgamma-Aminobutyric AcidGlucosidesHemiplegiaHypnotics and SedativesMaleMiceMotor ActivityNeuroprotective Agentsacacetin-7-O-glucosideAnticonvulsantsFlavonoidsgamma-Aminobutyric AcidGlucosidesHypnotics and SedativesNeuroprotective AgentsFlavonoidsfunctional recoveryGABAAhemiplegia

Identifiers

PMID26410208
PMCPMC4923766
OpenAlexW2217477379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.